hiroshi kobayashi - Gynecology

Author Information

Dr. Hiroshi Kobayashi is affiliated with the Department of Obstetrics and Gynecology at Nara Medical University in Kashihara, Nara, Japan, as well as with Ms.Clinic MayOne in the same city. His work primarily focuses on gynecological conditions and cancers, with a particular emphasis on ovarian cancer, endometriosis, and adenomyosis.

Research Contributions

Dr. Hiroshi Kobayashi has made significant contributions to the field of gynecology through his research on a variety of topics. His 2022 papers highlight his work on identifying biomarkers for asymptomatic venous thromboembolism in ovarian cancer patients and exploring the protective mechanisms of macrophages in endometriotic cells. His work on redox homeostasis in ovarian cancer and endometriosis, and his proposals for treatment algorithms for symptomatic adenomyosis, demonstrate his comprehensive approach to understanding and treating gynecological conditions. Dr. Kobayashi has also extensively researched the RAGE pathway's involvement in preeclampsia and the relationship between iron levels and dysmenorrhea severity in ovarian endometrioma patients.

Aliases

Hiroshi Kobayashi

Publication and Citation Metrics

Metric	Value
Total Citations	4250
H-index	33
Total Papers	283

Publications:

Tissue factor pathway inhibitor 2 as a serum marker for diagnosing asymptomatic venous thromboembolism in patients with epithelial ovarian cancer and positive D-dimer results.

DOI: 10.3892/mco.2021.2479

Year: 2022

Macrophages Protect Endometriotic Cells Against Oxidative Damage Through a Cross-Talk Mechanism

DOI: 10.1007/s43032-022-00890-6

Year: 2022

Revisiting therapeutic strategies for ovarian cancer by focusing on redox homeostasis

DOI: 10.3892/ol.2022.13200

Year: 2022

Effects of iron-related compounds and bilirubin on redox homeostasis in endometriosis and its malignant transformations

DOI: 10.1515/hmbci-2021-0065

Year: 2021

Proposal for developing treatment algorithms of women with symptomatic adenomyosis: A single‐center experience

DOI: 10.1111/jog.14904

Year: 2021

Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary

DOI: 10.1007/s10147-021-01914-y

Year: 2021

P-005. Involvement of RAGE pathway in visceral adipose tissue in preeclampsia

DOI: 10.1016/j.preghy.2021.07.040

Year: 2021

Chemoprevention for Ovarian Cancer

DOI: 10.1007/978-981-16-4521-1_10

Year: 2021

Clinicopathological characteristics and imaging findings to identify adenomyosis‐related symptoms

DOI: 10.1002/rmb2.12409

Year: 2021

Relationship between Magnetic Resonance Relaxometry R2 Value and Iron Levels and the Severity of Dysmenorrhea in Patients with Ovarian Endometrioma

DOI: 10.47275/2692-0948-126

Year: 2021

Why Does BBT Rise?

What Gynecological Procedures Can Be Performed Using Single Port Laparoscopy?

Can You Have a Pap Smear During Your Period?

How Often Should One Get Examined?

How to Use a Transdermal Patch?

Why Are Encryption Protocols Important in Gynecology?

Why do people fear gynecological exams?

How are Quality Standards Developed?

What are Infrequent or Prolonged Menstrual Periods?

What is the Role of ALP in Pregnancy?

Partnered Content Networks

Relevant Topics